Literature DB >> 6091794

Effects of prostaglandin F2 alpha on agonist-induced progesterone production in cultured bovine luteal cells.

J L Pate, W A Condon.   

Abstract

The present study examines the effects of prostaglandin F2 alpha (PGF2 alpha) on basal and agonist-stimulated progesterone (P4) production utilizing long-term, serum-free cultures of bovine luteal cells. During the first 24 h of culture, PGF2 alpha had no significant effect on P4 production, and was unable to inhibit either luteinizing hormone (LH)- or dibutyryl cAMP (dbcAMP)-stimulated increases in P4. Treatment with PGF2 alpha on Day 1 produced a moderate, nonsignificant (P greater than 0.05) inhibition of cholera toxin (CT)- and forskolin (FKN)-stimulated P4 synthesis. Beyond Day 1 of culture (Days 3-11), PGF2 alpha continued to have no significant effect on basal P4 production, but suppressed all stimulatory effects of LH, dbcAMP, CT and FKN. Treatment with indomethacin inhibited prostaglandin synthesis by the cultured cells and also elevated levels of P4 from Days 3 to 11 of culture. Concurrent treatment with PGF2 alpha suppressed the steroidogenic effect of indomethacin. From these studies it was concluded that in cultured bovine luteal cells, PGF2 alpha does not affect basal P4 production, but is able to inhibit agonist-stimulated P4 production at a site beyond the accumulation of cAMP. This inhibitory effect is not apparent during the first 24 h of culture, but appears after Day 1 and persists throughout the remaining 10 days of the culture period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091794     DOI: 10.1095/biolreprod31.3.427

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  8 in total

1.  Expression of superoxide dismutase, catalase and glutathione peroxidase in the bovine corpus luteum: evidence supporting a role for oxidative stress in luteolysis.

Authors:  B R Rueda; K I Tilly; T R Hansen; P B Hoyer; J L Tilly
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

2.  Prostaglandin F2α reduces steroidogenic acute regulatory (StAR) protein messenger ribonucleic acid expression in the rat ovary.

Authors:  T W Sandhoff; M P McLean
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

Review 3.  History, insights, and future perspectives on studies into luteal function in cattle.

Authors:  Cecily V Bishop; Vimal Selvaraj; David H Townson; Joy L Pate; Milo C Wiltbank
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

4.  Expression of costimulatory molecules in the bovine corpus luteum.

Authors:  Matthew J Cannon; John S Davis; Joy L Pate
Journal:  Reprod Biol Endocrinol       Date:  2007-01-31       Impact factor: 5.211

5.  Luteal Lipids Regulate Progesterone Production and May Modulate Immune Cell Function During the Estrous Cycle and Pregnancy.

Authors:  Camilla H K Hughes; Remy Bosviel; John W Newman; Joy L Pate
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-04       Impact factor: 5.555

6.  Form of Supplemental Selenium Affects the Expression of mRNA Transcripts Encoding Selenoproteins, and Proteins Regulating Cholesterol Uptake, in the Corpus Luteum of Grazing Beef Cows.

Authors:  Sarah N Carr; Benjamin R Crites; Joy L Pate; Camilla H K Hughes; James C Matthews; Phillip J Bridges
Journal:  Animals (Basel)       Date:  2022-01-27       Impact factor: 2.752

7.  Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves caspase-8 and is defective in caspase-3 deficient mice.

Authors:  Silvia F Carambula; James K Pru; Maureen P Lynch; Tiina Matikainen; Paulo Bayard D Gonçalves; Richard A Flavell; Jonathan L Tilly; Bo R Rueda
Journal:  Reprod Biol Endocrinol       Date:  2003-02-11       Impact factor: 5.211

8.  Stepwise activation of the gonadotropic signal transduction pathway, and the ability of prostaglandin F2alpha to inhibit this activated pathway.

Authors:  J E Väänänen; S Lee; C C Väänänen; B H Yuen; P C Leung
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.